More tools:Markets·Screener·Research·Chat

cbdMD, Inc. Common Stock (YCBD) Financial Statements

cbdMD, Inc. Common Stock
SIC 2844 · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS
FIGI BBG00J3H4LJ6
XASE · usd
0.49▼ 0.01 (-1.56%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value—
Trailing P/E—
Price / Sales
EV / Revenue—
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt—
Trading Information
Previous Close0.50
Day's Range0.47 – 0.51
52-Week Range0.45 – 2.56
Volume70.9K
Avg Volume209.1K
Share Statistics
Shares Outstanding
Employees42
ExchangeXASE
Listed2017-11-17
Share count as of August 13, 2026
Loading Income Statement…
Key questions about cbdMD, Inc. Common Stock (YCBD)
What is cbdMD, Inc. Common Stock's Market Cap?
cbdMD, Inc. Common Stock's Market Cap is $5.5M, based on as-reported figures from SEC (XBRL) filings.
What is cbdMD, Inc. Common Stock's Price / Sales?
cbdMD, Inc. Common Stock's Price / Sales is 0.3×, based on as-reported figures from SEC (XBRL) filings.
What is cbdMD, Inc. Common Stock's Revenue (TTM)?
cbdMD, Inc. Common Stock's Revenue (TTM) is $20.9M, based on as-reported figures from SEC (XBRL) filings.
What is cbdMD, Inc. Common Stock's Net Income (TTM)?
cbdMD, Inc. Common Stock's Net Income (TTM) is -$3.1M, based on as-reported figures from SEC (XBRL) filings.
What is cbdMD, Inc. Common Stock's EBITDA?
cbdMD, Inc. Common Stock's EBITDA is -$1.9M, based on as-reported figures from SEC (XBRL) filings.
What is cbdMD, Inc. Common Stock's Diluted EPS (TTM)?
cbdMD, Inc. Common Stock's Diluted EPS (TTM) is -0.27, based on as-reported figures from SEC (XBRL) filings.
What is cbdMD, Inc. Common Stock's EBITDA Margin?
cbdMD, Inc. Common Stock's EBITDA Margin is -9.0%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Gross Sales
Total Net Sales
YoY growth+20.6%+18.8%-1.9%+3.6%
Cost of sales
Gross Profit
% of revenue54.7%57.7%59.8%58.8%
Operating expenses
Loss from operations
% of revenue-20.4%-14.2%-5.7%-14.5%
Decrease in fair value of convertible debt
Interest income, net
Loss before provision for income taxes
Net Loss
% of revenue-20.3%-14.1%-5.6%-14.4%
Preferred dividends
Net Loss attributable to cbdMD, Inc. common shareholders
Basic and Diluted earnings per share (in dollars per share)—